Dr. Bailes provided a comprehensive review of national legislative and regulatory activities affecting clinical oncologists. Topics addressed include health care reform and the status of legislation impacting Medicare payment for cancer care.

This talk took place on Thursday, July 15th, 2010 at The Palace Hotel, 2 New Montgomery Street, San Francisco (415-512-1111).

Download the presentation here.

This event was held in conjunction with ASCO's Best of ASCO San Francisco meeting.

Support for this meeting is anticipated from Alexion Pharmaceuticals, Astra Zeneca, Bayer Healthcare/Onyx Pharmaceuticals, biogenIDEC, Bristol-Myers Squibb Oncology, Celgene, Centocor Ortho Biotech, Cephalon Oncology, Genentech BioOncology, Genomic Health, Merck, Millennium, Novartis Oncology, OSI Pharmaceuticals, Pfizer Oncology, Sanofi Aventis Oncology, and US Oncology Physician Services.